J. Goldman & Co LP - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 137 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$3,593,000
-2.9%
710,798
+18.5%
0.27%
+5.1%
Q2 2019$3,702,000–600,000–0.26%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2019.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders